• Congress
  • HemaSphere
  • About EHA
  • Search
  • Connect & Network
  • Clinical practice
  • Education & Training
  • Research & Innovation
Join EHA Login
  • EHA2025 Congress
  • Meetings
  • Membership and benefits
  • EHA2025 details and deadlines
  • EHA2025 program
  • EHA2025 access and site information
  • EHA2025 delegate services
  • Congress platform
  • Accommodation
  • Media registration
  • Abstract submission
  • Sponsorship opportunities
  • Travel grants
  • Sustainability
  • Full membership
  • Junior membership
  • Trial membership
  • Healthcare-affiliated professional membership
  • Emeritus membership
  • Joint EHA and national society membership
  • Using MyEHA

EHA2025 Congress

  • June 12–15, 2025
  • Milan, Italy
  • Hybrid
  • Our guidelines initiative
  • Guidelines by areas of disease
  • Guidelines endorsed by EHA
  • EHA Guidelines app
  • Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelines
  • Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group
  • Recommendations regarding splenectomy in hereditary hemolytic anemias
  • Recommendations for Pregnancy in Rare Inherited Anemias
  • The Use of Next-generation Sequencing in the Diagnosis of Rare Inherited Anaemias: A Joint BSH/EHA Good Practice Paper
  • EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer
  • Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance
  • Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report
  • ESC Guidelines on cardio-oncology
  • Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults
  • Antifungal prophylaxis in adult patients with acute myeloid leukemia treated with novel targeted therapies
  • Human immunodeficiency virus-associated Lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
  • Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
  • Guidelines for the Use and Reporting of Patient-Reported Outcomes in Multiple Myeloma Clinical Trials
  • Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
  • Recommendations for diagnosis and treatment of methemoglobinemia
  • The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children
  • Management of Pregnancy in Rare Inherited Anemias
  • European guidelines on treatment and supportive measures in chronic neutropenias
  • Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment, and follow-up

EHA2025 Congress

  • June 12–15, 2025
  • Milan, Italy
  • Hybrid
  • EHA Campus
  • Learning paths
  • Tests and tools
  • Mentoring and career development
  • European Hematology Curriculum
  • Lighting the Flame program
  • EHA Diagnosis
  • EHA Exam
  • Progress Test
  • Career comparison tool
  • EHA Mentorship Program
  • Master Class
  • Research training programs

EHA2025 Congress

  • June 12–15, 2025
  • Milan, Italy
  • Hybrid
  • HemaSphere
  • Specialized Working Groups
  • Grants
  • Topics-in-Focus program
  • Support for SWG scientific meetings
  • SWG Grants
  • How to apply to join an SWG
  • EHA Research Grants
  • EHA Bilateral Collaborative Grant
  • EHA Grants Hall of Fame
  • EHA Innovation Grant
  • EHA Kick-off Grant
  • EHA Research Mobility Grant
  • Non-EHA funding opportunities
  • Scope of our grants
  • Precision Hematology Topics-in-Focus program
  • Hemoglobinopathies Topics-in-Focus program

EHA2025 Congress

  • June 12–15, 2025
  • Milan, Italy
  • Hybrid
  • Connect & Network
    • EHA2025 Congress
      • EHA2025 details and deadlines
      • EHA2025 program
      • EHA2025 access and site information
      • EHA2025 delegate services
      • Congress platform
      • Accommodation
      • Media registration
      • Abstract submission
      • Sponsorship opportunities
      • Travel grants
      • Sustainability
    • Meetings
    • Membership and benefits
      • Full membership
      • Junior membership
      • Trial membership
      • Healthcare-affiliated professional membership
      • Emeritus membership
      • Joint EHA and national society membership
      • Using MyEHA
  • Clinical practice
    • Our guidelines initiative
    • Guidelines by areas of disease
      • Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelines
      • Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group
      • Recommendations regarding splenectomy in hereditary hemolytic anemias
      • Recommendations for Pregnancy in Rare Inherited Anemias
      • The Use of Next-generation Sequencing in the Diagnosis of Rare Inherited Anaemias: A Joint BSH/EHA Good Practice Paper
      • EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer
      • Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance
      • Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report
      • ESC Guidelines on cardio-oncology
      • Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults
      • Antifungal prophylaxis in adult patients with acute myeloid leukemia treated with novel targeted therapies
      • Human immunodeficiency virus-associated Lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
      • Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
      • Guidelines for the Use and Reporting of Patient-Reported Outcomes in Multiple Myeloma Clinical Trials
      • Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
      • Recommendations for diagnosis and treatment of methemoglobinemia
      • The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children
      • Management of Pregnancy in Rare Inherited Anemias
      • European guidelines on treatment and supportive measures in chronic neutropenias
      • Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment, and follow-up
    • Guidelines endorsed by EHA
    • EHA Guidelines app
  • Education & Training
    • EHA Campus
    • Learning paths
      • European Hematology Curriculum
      • Lighting the Flame program
    • Tests and tools
      • EHA Diagnosis
      • EHA Exam
      • Progress Test
    • Mentoring and career development
      • Career comparison tool
      • EHA Mentorship Program
      • Master Class
      • Research training programs
  • Research & Innovation
    • HemaSphere
    • Specialized Working Groups
      • Support for SWG scientific meetings
      • SWG Grants
      • How to apply to join an SWG
    • Grants
      • EHA Research Grants
      • EHA Bilateral Collaborative Grant
      • EHA Grants Hall of Fame
      • EHA Innovation Grant
      • EHA Kick-off Grant
      • EHA Research Mobility Grant
      • Non-EHA funding opportunities
      • Scope of our grants
    • Topics-in-Focus program
      • Precision Hematology Topics-in-Focus program
      • Hemoglobinopathies Topics-in-Focus program
  • Congress
  • HemaSphere
  • About EHA
  • Search
Join EHA Login
  1. Home
  2. About EHA
  3. EHA Awards
  4. Previous awards
  5. José Carreras Award
Join EHA
  • Full membership
  • Junior membership
  • 60-day trial
Get involved
  • Career development
  • Meetings
About us
  • Mission and vision
  • Jobs
  • Sponsor EHA
  • Contact us
Follow us
  • Privacy statement
  • Terms and conditions
  • Subscribe
Copyright © 2025

Register for EHA2025

Late registration ends on June 15

EHA2025 Congress